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ELECTROCARDIOGRAPHIC CHANGES DURING LITHIUM TREATMENT 
A. VENKOBA RAO
1 AND N. HARIHARASUBRAMANIAN* 
Electrocardiographic changes have been 
reported during therapy with psychotropic 
drugs—such as tricyclic anti-depressants 
(Schou 1963 ; Burrows et al., 1976 ; Reed 
and McKim 1978) and lithium (Tilkian 
et al., 1976a, 1976b; Wren and Dana 1976; 
Jefferson and Greist 1979). Lithium 
Carbonate affects ionic fluxes across cell 
membranes—-particularly those of sodium, 
potassium, calcium and magnesium (Carman 
et al., 1974; Durell, 1974) and thereby in-
fluences excitable tissues, like the nervous 
system and the heart. The changes in-
duced in the heart are quite subtle and 
insidious and may be detected electrophy-
siologicaly without any manifest symptoms 
of cardiac involvement. The changes are 
often observed with serum lithium concen-
trations well within the therapeutic range 
and hence are to be sought for during 
routine maintenance therapy. The present 
paper describes the electrocardiographic 
changes noted in patients attending the 
Lithium clinic, Erskine hospital, Madurai 
during their regular follow-up. Observa-
tions from the Lithium clinic on the serum 
lithium—oral dose correlation, factors affect-
ing therapeutic response and side effects 
of lithium therapy have been published 
elsewhere (Venkoba Rao and Harihara-
subramanian, 1977, 1978). 
MATERIAL AND METHOD 
Thirty patients (19 M : 11 F) belonging 
to various age groups from 21-57 years 
attending the Lithium clinic were chosen. 
At the time of invsetigation, they were on 
lithium carbonate for periods varying from 
one to forty-three months (Table 1). The 
daily oral dose of lithium ranged from 
TABLE 1 
Age 
(in yrs. 
21—30. 
31—40 
41—50 
51—60 
Total 
Less th 
12 
raonl 
M. 
. 1 
2 
3 
6 
Duration of therapy 
an 
ths 
F. 
2 
1 
3 
12--24 
months 
M. 
1 
1 
3 
2 
7 
F. 
1 
2 
3 
More than 
24 
months 
M. 
2 
1 
3 
6 
F. 
.. 
2 
3 
5 
Total 
M F. 
4 3 
4 5 
6 3 
5 
19 11 
1 Professor and Head, Department of Psychiatry 
2 AssisUnt Professor of Physiology, 
M=MaIe, F=Female. 
900-1500 mg. and the serum lithium con-
centrations were within 0.8 to 1.2 mEq/L 
at the time of study. The initial EGG 
records of the patients before commence-
ment of lithium therapy were available for 
comparison. A standard 12-lead EGG 
was taken along with a simultaneous deter-
mination of serum lithium and potassium 
levels by flame photometry. The EGG 
records were compared with those obtained. 
Lithium was withdrawn from three 
patients who maintained psychiatric remis-
sion but had significant ECG changes. An 
ECG was taken during the "drug-free" 
period. At the time of preparation of this 
report, lithium has been restarted for one 
of them who had relapsed and an EGG 
recorded after resumption of the drug. 
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RESULTS Out of the 30 patients studied, EGG 
TABLE 2-E. C. G. Changes during Lithium
 chanS
e
s
 wer
e detected in 20. The changes 
Therapy observed were 
(i) Sinus bradycardia of 60/minute or 
less was seen in five 
Change 
No. 
of 
patients 
value 
(Mean±S.D.) 
Bradycardia 60/mt 
or less). 
Prolonged P. R. in-
terval (observed 
P.R.=0.2 sec. and 
P,-PRf 0.01 sec.) 
Prolonged 0_T interval 
(QTC 0.42 sec.) 
T wave abnormalities 
(Flat or isoelectric or 
inverted T waves 
seen in more than 
one standard lead 
in conjunction with 
normal QRS com-
plexes) 
13 
11 
57.4±3.04/mt 
t = 7.25 p< 0.001 
PRo</0.21i0.03 sec. 
t-4.78 p<0.01 
PR0-PRf 
0.002 sec. t 
p<0.01. 
0.485±0.04 sec. 
t=5.36 p<0.001 
0.05± 
5 = 5.85 
(ii) PR interval was prolonged to more 
than 0.2 sec. in six patients. In 
TABLE 3—Bradycardia (Heart Rate 
or Less) 
(N=7) 
60lmt. 
Patient No. 
1 
2 
12 
14 
26 
27 
28 
Mean±S.D. 
Pre-lithium 
100 
93 
77 
83 
78 
84 
79 
85.8±9.9 
After lithium 
54 
53 
60 
53 
56 
60 
59 
57.4±3.04* 
*t = 7.25, p<0.001. 
TABLE 4—Prolonged PR Interval (jV=6) 
(Observed : 0.2 Sec. or more ; at or exceeding upper limit for the heart-rate ; deviating 
from the frequency-corrected interval (P-Rf) by more than 0.04 Sec.) 
Patient — 
No. 
1 
6 
7 
17 
23 
25 
Mean 
± 
S.D. 
•t=4.78 
*»t=.5.85 
PR. 
0.14 
0.12 
0.16 
0.16 
0.14 
0.16 
0.146 
± 
0.016 
p< 0.01 
p< 0.01 
Pre-lithium 
HR 
100 
115 
89 
115 
90 
68 
PRn 
0.19 
0.18 
0.20 
0.18 
0.20 
0.20 
PRf 
0.135 
0.13 
0.142 
0.13 
0.142 
0.158 
PRo : observed P 
HR0 : 
d 
(PR.-
PRr) 
0.005 
0.01 
0.018 
0.03 
0.002 
0.002 
0.01 
± 
0.01 
—R interval 
PR0 
0.24 
0.20 
0.20 
0.20 
0.20 
0.20 
0.213* 
± 
0.03 
1. 
heart rate/mt. 
After lithium 
HR 
54 
75 
68 
80 
89 
71 
PRU 
0.21 
0.19 
0.20 
0.19 
0.19 
0.20 
PRf 
0.184 
0.154 
0.16 
0.15 
0.16 
0.158 
d 
(PRo-
PRf) 
0.056 
0.046 
0.040 
0.00 
0.04 
0.042 
0.05** 
± 
0.002 
PRn : upper limit of interval for heart rate 
PRf : frequency-correcetd P—R interval, 
d : deviation of P-R, from P-Rf ELECTROCARDIOGRAPHIC CHANGES DURING LITHIUM TREATMENT 137 
TABLE 5—Prolonged QTC Interval (JV=13) 
(QT > 0.42 Sec. in men; > 0.43 Sec. in 
women) 
Patient No. 
2 
4 
5 
8 
12 
14 
17 
21 
25 
26 
30 
33 
34 
Mean±S.D. 
Pre-lithium 
0.40 
0.38 
0.40 
0.40 
0.35 
0.40 
0.40 
0.40 
0.32 
0.34 
0.40 
0.36 
0.37 
0.41 ±0.04 
After lithium 
0.46 
0.47 
0.45 
0.45 
0.50 
0.43 
0.43 
0.47 
0.43 
0.43 
0.44 
0.43 
0.43 
0.485±0.041* 
*t=5.36 p<0.001. 
these, the observed PR interval 
also deviated from the standard 
frequency-determined PR interval 
(PRf) by more than 0.05 sec. 
(iii) Rate corrected QT interval (QTc) 
was more than 0.43 sec. in thirteen 
cases 
(iv) Significant T wave changes, i.e., 
reduction in amplitude, flattening 
or isoelectricity or inversion of T 
waves in association with normal 
QRS complexes in the same lead, 
occurring in more than one stand-
ard lead were noted in eleven 
patients 
The EGG changes resolved on with-
drawal of lithium ; and in one in whom 
the drug was resumed after a drug-free 
interval the ECG changes set in again. 
The frequency of occurrence of EGG 
changes was analysed in correlation with 
factors such as age, duration of therapy, 
serum lithium and potassium concen-
trations. 
Age : A significantly higher proportion 
of people in the older age group of more 
than 40 years (85.7%) had EGG changes. 
TABLE 6—E. C. G. Changes correlated with Age 
Age group 
Per cent of 
patients with 
changes 
Less than 40 years 
More than 40 years 
50.0 (8 out of 16) 
85.7 (12 out of 14) 
X»=4.27, d.f. = l, p<0.05. 
Duration of therapy : A greater per cent 
of people who were on lithium for more 
than two years had EGG changes (90.9%) 
than those who were on lithium for 1-2 
years (70%) or for less than one year 
(33.3%). 
TABLE 7—E. C. G. Changes correlated with 
duration of Therapy 
'Duration of therapy 
Per cent of 
patients with 
changes 
Less than 12 months 
12—24 months 
More than 24 months 
33.3 (3 out of 9) 
70.0 (7 out of 10) 
90.9 (10 out of 11) 
X' =7.05 p<0.05. 
Serum lithium and potassium concentrations : 
Irrespective of the EGG changes, all the 
patients under study had optimal serum 
lithium levels between 0.6 and 1.2 mEq/L 
and there was no significant difference 
between the two groups. The serum potas-
sium levels were within the physiological 
range 3.6-5.0 mEq/L and did not differ 
between the two groups. 
DISCUSSION : 
The findings indicate that lithium 
therapy tends to produce (i) slowing of 
sinus rhythm ; (ii) prolongation of intra-138  A. VENKOBA. RAO AND N. HARIHARASUBRAMANIAN 
ventricular conduction and(iii) interference 
with repolarisation. The changes are pos-
sibly influenced by many factors such as age, 
duration of therapy and the pre-existing 
cardiac status. Greater incidence of these 
changes in older people bears out this 
suggestion. Longer the term of adminis-
tration of lithium more frequent are the 
effects—this points to possible cumulative 
effects of lithium on the heart over time. 
The effects of lithium ion on the heart 
were first studied in 1875 (Hisse, 1875) 
when intravenous infusion of lithium in 
frogs, rabbits and doves produced diastolic 
arrest. Similar effects were reported by 
Krumhoff (1903). In the 1940's, indis-
criminate use of lithium chloride as a salt-
substitute, in the face of restricted salt intake 
led to fatal lithium poisoning and this marked 
the exit of lithium from the field of cardio-
logy but at the same time, its advent in 
psychiatry (Cade, 1949; Corcoran et al., 
1949; Hanlon et al., 1949; Waldron, 1949). 
Wolferth et al. (1945) reported ST and T 
wave changes following application of 
lithium lactate to the surface of the heart. 
In man, the following effects of lithium 
on the EGG have been noted ; flat or 
inverted T waves (Schou 1968, Demers 
and Heninger 1970, 1971 ; Kochar et al. 
1971, Makeeva et al. 1974-75, Wren and 
Dana 1976) which are benign and re-
versible and not to be misconstrued as 
organic heart disease in absence of other 
symptoms (Jefferson and Griest 1979), ven-
tricular irritability and ventricular arrhyth-
mias (Tseng, 1971, Rosenquist et al. 1971, 
Tangedahl and Gau 1972, Middlehoff and 
Paschen 1974), myocarditis (Tseng 1971, 
Swedberg and Winblad, 1974), sinoatrial 
block (Murayama et al. 1972, Eliasen and 
Andersen 1975, William et al. 1975, Wilson 
it al. 1976), reversible sinus dysfunction 
and first degree A-V block (Jaffe, 1977). 
In "lithium-babies", there are reports of 
congenital anomalies of heart and blood 
vessels (Weinstein and Gold-field 1975, 
Sethi, 1978) and reversible T wave changes 
and bradycardia (Tunnessen and Hertz 
1972, Stothers et al. 1973, Stevens et al. 
1974). 
Bradycardia is the consequence of re-
duced automaticity due to slowing of spon-
taneous diastolic depolarisation (Hoffman 
and Gramfield, 1960). In the present 
study, one of the patients who had sinus 
bradycardia (Patient No. 14) developed 
features of hypothyroidism about three 
months prior to the EGG recording and the 
brady cardia may be part of the hypothyroid 
state. In others however it appears to be 
a specific effect of lithium. 
Slowing of intracardiac conduction and 
repolarisation as indicated by prolongation 
of PR and QTc intervals is possibly due 
to lithium incompletely substituting for 
sodium and potassium in the myocardium 
(Keynes and Swan 1959; Carmeliet, 1964). 
In animal and tissue studies lithium has 
been reported to decrease spontaneous de-
poralisation, induce decremental conduc-
tion and delay conduction through the A-V 
node and ventricle (Rieciutti et al. 1971; 
Singer and Rotenbcrg 1973). Reduction 
in conduction velocity and decremental 
conduction results from a fall in mean rest-
ing membrane potential and in trans-
membrane potential just prior to initiation 
of action potential (Hodgkin and Huxley 
1952, Van Dam et al, 1963), these being 
induced by lithium replacing sodium. 
The QTc interval bears an inverse 
relationship to plasma calcium levels. Al-
though plasma calcium was not determined 
in the present study, it may well be involved 
in the EGG changes. Prolongation of 
conduction may also be due to increased 
vagal tone possibly induced by lithium. 
Reversible T wave flattening or inver* 
sion is die most commonly noted cardio-
vascular effect of lithium. This is thought 
to be caused by an intracellular hypoka-
lemia that occurs because lithium readily 
enters cardiac cells but is removed slowly, 
thus replacing some intracellular potassium 
(McKusick 1954; Demers and Heninger ELECTROCARDIOGRAPHIC CHANGES DURING LITHIUM TREATMENT 
1970 ; Kochar et al. 1971). Intracellular 
hypokalemia can occur even with a normal 
serum potassium level because of renal 
compensatory mechanisms (Baer et al. 1970; 
Singer and Rotenberg 1973). 
The effects of lithium on the heart 
may also be indirect—-alteration of myo-
cardial carbohydrate metabolism before the 
appearance of conduction abnormalities, 
partial inhibition of positive chronotropic 
effect of adrenaline and pressor effects of 
noradrenaline and inhibition of cyclic AMP 
(Fann et al. 1972; Horgan et al. 1973; Misu 
et al. 1975 ; Jaffe 1977). 
It is important to note that, unlike the 
tricyclic antidepressants whose magnitude 
of EGG change is reported to be directly 
proportional to the plasma levels (Reed 
and McKim 1978), the EGG changes have 
occurred with serum lithium well within 
the therapeutic range. 
The EGG changes observed in the pre-
sent study are considered to be primarily 
due to lithium therapy because the changes 
were seen in patients with previously normal 
EGG's and because all the patients received 
only lithium carbonate as the principal 
therapeutic agent, being supplemented only 
intermittently for short periods with tri-
cyclic antidepressants and tranquillisers. 
The disappearance of these changes follow-
ing withdrawal of lithium in three cases 
in the present study and reappearance of 
T wave abnormalities in one, following 
resumption of lithium is clear evidence 
that the changes are due to lithium. 
CONCLUSION 
The occurrence of significant electro-
cardiographic changes during long term 
lithium therapy with serum lithium well 
within therapeutic range and with no 
obvious ionic disturbances and while patients 
are asymptomatic, suggests the need for 
occasional EGG monitoring of patients 
treated with lithium to forestall any sub-
sequent impairment of cardiac function. 
However, Tilkian et al. (1976b) from a 
comprehensive study conclude that lithium 
does not adversely affect cardiac function 
as measured by exercise tolerance tests and 
it is held that there is no contraindication 
for lithium even in patients with heart 
disease when there are clear psychiatric 
indications for its use (Huff 1976) ; by 
and large, reported evidence in both animals 
and man and our observations of reversi-
bility of EGG changes suggests that lithium 
is well tolerated. Severe cardiovascular 
complications, even at toxic doses are said 
to occur uncommonly and often as secondary 
complications (Jefferson and Griest 1979). 
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